Commodore Capital LP's Form 4 filing
Satsuma Pharmaceuticals, Inc. (STSA) · filed Nov 29, 2021
- Accession no.
- 0000905718-21-001545
- Filed
- Nov 29, 2021
- Trade date
- Nov 24, 2021
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction. Open-market purchases total $15.8K. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Commodore Capital LPCIK 0001831942 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 24, 2021 | Common Stock, par value $0.0001 per share | PPurchaseAcquired | +2,922 | $5.42 | +$15,837.24 | 3,711,286 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.